University of Helsinki / Cancer Center / Helsinki University Central Hospital / Haartman Institute / /
IndustryTerm
tumor site / imaging / /
MedicalCondition
tumor / ovarian cancer / injected and non-injected tumors / Cancer / tumors / Disease / Finland Tumor / systemic tumor / circulatory carcinoma / /
MedicalTreatment
chemotherapy / surgery / immunotherapy / /
Organization
HUSLAB / 3Docrates Cancer Center / University of Helsinki / Helsinki / Center for Science Ltd / Helsinki University Central Hospital / Haartman Institute / / /
Repeated intratumoral administration of ONCOS-102 leads to robust cellular and transcriptional immune activation at tumor site in an ovarian cancer patient Vassilev L.1, Hemminki A.2, Joensuu T.3, Jäger E.4, Karbach J.4